These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24618716)

  • 1. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
    Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
    PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
    Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
    Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
    Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
    Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different antiviral effects of IFNα and IFNβ in an HBV mouse model.
    Zhou Y; Li S; Tang Z; Xu C; Huang S; Wu J; Dittmer U; Dickow J; Sutter K; Lu M; Yang D; Song J
    Immunobiology; 2017 Mar; 222(3):562-570. PubMed ID: 27839836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
    Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
    Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B.
    Li L; Shen H; Li A; Zhang Z; Wang B; Wang J; Zheng X; Wu J; Yang D; Lu M; Song J
    Virol J; 2013 Jun; 10():214. PubMed ID: 23805945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
    Zou S; Du Y; Huang S; Chen M; Yang X; Li S; Chen Y; Han M; Li J; Yu Q; Littwitz-Salomon E; Huang H; Trilling M; Liu S; Pei R; Liu J; Wang B; Zheng X; Lu M; Dittmer U; Sun S; Yang D; Wu J
    J Virol; 2021 Nov; 95(24):e0003421. PubMed ID: 34550772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
    Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
    Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
    Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
    Yin W; Xu L; Sun R; Wei H; Tian Z
    Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis.
    Liu Q; Li J; Zong Q; Duan Z; Liu F; Duan W; Ruan M; Zhang H; Liu Y; Zhou Q; Wang Q
    Int Immunopharmacol; 2024 Jun; 134():112219. PubMed ID: 38733823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection.
    Li Y; Luo H; Hu X; Gong J; Tan G; Luo H; Wang R; Pang H; Yu R; Qin B
    Pol J Microbiol; 2024 Jun; 73(2):217-235. PubMed ID: 38905278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressant dexamethasone can significantly extend the expression of hepatitis B virus antigens in the HBV mouse model by hydrodynamic transfection method].
    Guo YJ; Wang W; Sun SH; Zeng DB; Zhao GY; Yu H; Guo Y; Tan WJ; Lu SC; Zhou YS
    Bing Du Xue Bao; 2010 Jan; 26(1):20-6. PubMed ID: 20329554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
    Zhang J; Liu K; Zhang G; Ling N; Chen M
    Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.
    Limothai U; Chuaypen N; Poovorawan K; Chotiyaputta W; Tanwandee T; Poovorawan Y; Tangkijvanich P
    J Viral Hepat; 2019 Dec; 26(12):1481-1488. PubMed ID: 31446638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.